| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | P W Soothill | |
| S Illanes | |||
| N Avent | |||
| P2860 | cites work | Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum | Q24567463 |
| A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma | Q33361680 | ||
| Fetal cells in the maternal circulation: feasibility for prenatal diagnosis | Q33650187 | ||
| Fetal RhD genotyping from maternal plasma | Q33780684 | ||
| Presence of fetal DNA in maternal plasma decades after pregnancy | Q34137715 | ||
| Management of anti-Rhesus-D antibodies in pregnancy: a review from 1994 to 1998. | Q34339553 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Rapid clearance of fetal DNA from maternal plasma | Q34388637 | ||
| mRNA of placental origin is readily detectable in maternal plasma. | Q34960254 | ||
| Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed | Q35043252 | ||
| Circulating fetal DNA: its origin and diagnostic potential-a review | Q35699978 | ||
| Fetal cell-free nucleic acids in the maternal circulation: new clinical applications | Q35835705 | ||
| The biology and diagnostic applications of plasma RNA. | Q35835719 | ||
| A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant | Q35870526 | ||
| Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction | Q35888435 | ||
| Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn | Q35976544 | ||
| MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. | Q36986986 | ||
| Inability to detect cell free fetal DNA in the urine of normal pregnant women nor in those affected by preeclampsia associated HELLP syndrome | Q38347083 | ||
| Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction--a pilot study | Q40588231 | ||
| Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service | Q40626763 | ||
| Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA). | Q42873893 | ||
| Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling | Q43073656 | ||
| Rapid clearance of fetal cells from maternal circulation after delivery | Q44976784 | ||
| Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR. | Q45289004 | ||
| Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms | Q47423342 | ||
| Size distributions of maternal and fetal DNA in maternal plasma. | Q47432593 | ||
| Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. | Q47889241 | ||
| [First trimester fetal sex determination in maternal serum using real-time PCR]. | Q54295517 | ||
| Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia. | Q54703442 | ||
| Strategies for the rapid prenatal diagnosis of chromosome aneuploidy. | Q54707408 | ||
| The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. | Q54777020 | ||
| Methods to Increase the Percentage of Free Fetal DNA Recovered From the Maternal Circulation | Q56001879 | ||
| Impact of Formaldehyde on the in Vitro Proportion of Fetal DNA in Maternal Plasma and Serum | Q56001880 | ||
| Detection of Y chromosome-specific DNA in the plasma and urine of pregnant women using nested polymerase chain reaction | Q56001883 | ||
| Circulating corticotropin-releasing hormone mRNA in maternal plasma: relationship with gestational age and severity of preeclampsia | Q57001286 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Can circulatory fetal DNA be used to study placentation at high altitude? | Q57108476 | ||
| Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia | Q57671390 | ||
| Prenatal exclusion of β thalassaemia major by examination of maternal plasma | Q58029823 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 317-22 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Ultrasound in Obstetrics and Gynecology | Q1817048 |
| P1476 | title | Cell-free fetal DNA in maternal plasma: an important advance to link fetal genetics to obstetric ultrasound | |
| P478 | volume | 25 |
Search more.